Nanostring technologies/biological products/hardegen
Ended Awarded
- Contract number
- HHSN26100022
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,126
Award facts
- Contract value 100% obligated
- $6,126.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98109, USA
Award details come from SAM.gov/FPDS.
About this award
Nanostring Technologies, Inc. received a contract award from the National Cancer Institute (NCI) on September 5, 2017, for biological products under a Blanket Purchase Agreement (BPA) call. The firm fixed price contract, valued at $6,126.00, was completed by October 5, 2017, with performance conducted at the company's Seattle, Washington facility. No set-aside designation was applied to this award. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools, including the nCounter Analysis Systems and GeoMx Digital Spatial Profiler, which are widely utilized for multiplexed digital detection and analysis of nucleic acids, proteins, and cells.
The award supports the NCI's biomedical research mission through the procurement of specialized laboratory equipment, reagents, assays, and testing services for genomic and molecular analysis. This transaction represents a continuation of Nanostring's established relationship with federal health agencies, as the company has previously provided similar products and services to multiple National Institutes of Health divisions and other government agencies. The company maintains significant federal contracting vehicles, including a $2.8 million blanket purchase agreement with the Defense Health Agency and a $596,881.45 indefinite delivery/indefinite quantity contract with the USDA Agricultural Research Service.
Quick answers
Who was awarded contract HHSN26100022?
HHSN26100022 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 5, 2017.
How much is contract HHSN26100022 worth?
The government has obligated $6,126 on HHSN26100022.
Is contract HHSN26100022 an order under another contract?
Yes. HHSN26100022 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract HHSN26100022 competed?
The extent of competition for HHSN26100022 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award